Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use methylphenidate hydrochloride extended-release tablets USP safely and effectively. See full prescribing information for METHYLPHENIDATE hydrochloride extended-release tablets USP. METHYLPHENIDATE hydrochloride extended-release tablets USP, for oral use CIIInitial U.S. Approval: 2000
Medication labelWhy this: Advisory · dailymed-prescription
Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65 [see Clinical Studies (14)].
- generic_name
- methylphenidate hydrochloride
- product_names
- Methylphenidate hydrochloride
- ndc
- 13811-709, 13811-709-10, 13811-706, 13811-706-10, 13811-707, 13811-707-10, 13811-708, 13811-708-10, 13811-710, 13811-710-10, 13811-710-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en